[April, 2023]
Message from our CEO
Dear Partners,
At REVIVO Biosystems, we are still feeling tremendous excitement over the recent launch of ReleGO™ and REVex™! I want to take this opportunity to reiterate my appreciation for your interest and support. I’d also like to share some details about our Dare to Act brand philosophy. Reflecting our corporate culture, it drives our operations and expands the level of engagement and support we provide.
Dare to Act characterizes our fearless, multidisciplinary approach to research. At REVIVO BioSystems, we encourage scientists and researchers to transcend the boundaries between scientific disciplines: to explore the intersection of biology and microfluidics; to expand the relationship between bioengineering and skincare. Our engineers are at their best when the challenge is greatest. Toxicologists, chemists, and pharmacologists are truly inspired as they dare to develop new, alternative, and more ethical methodologies. These innovators dare to push the boundaries, fully aware that as science advances, so too will humanity.
Dare to Act is our way of validating the trust you have placed in us. It facilitates the ongoing development of strong commercial propositions and the efficient generation of reliable support data for successful mechanistic safety and efficacy claim differentiation. Going from strength to strength, we build on our knowledge and unique expertise in 4D models to understand the mode of action of ingredients and actives. With us, you have access to the most realistic human tissue models and testing platform — models that mimic blood flow to recreate the dynamic conditions of life. Ultimately, anything is possible if you Dare to Act.
Dr. Massimo Alberti
CEO of REVIVO BioSystems
Our Dare-To-Act offer
Being the leading experts in realistic 4D human tissue models, we are here to provide you with the most effective support, methodology and solutions for your project requirements. Through our Dare-to-Act offer, our team of experts work closely with you to understand your needs. We develop your commercial claims strategies with you, execute your testing projects for better understanding your products’ modes of action and eventually translate unique supporting data into successful product claims for you to use in your commercial plans.
Recent Updates
We exhibited at in-cosmetics Global 2023 held in Barcelona, and were proud to have had the opportunity to showcase our innovative 4D dynamic skin-on-chip and organ-on-chip technology. Networking with industry friends, experts and professionals from all over the world resulted in many passionate discussions about the technology, and interest to adopt it. We are grateful that our technology platform was more than well-received, and we truly enjoyed sharing the unique benefits of our offerings to all of you who have visited us at the event and showed your support. Thank you!
We are committed to providing you with the latest skin-on-chip technology for in vitro safety, efficacy and permeation studies, and look forward to seeing you at our next exhibition at 25th World Congress of Dermatology.
Meanwhile, if you’d like to learn more about our products and services, visit our website or drop us a message with your questions at sales@revivobio.com
Additionally, we are thrilled to announce that REVIVO BioSystems has joined the Animal-Free Safety Assessment Collaboration (AFSA) family. As a company committed to providing innovative and ethical in vitro testing solutions, we believe that our alignment with this esteemed collaboration will accelerate our shared mission of supporting and encouraging animal-free testing methods in the cosmetics, personal care and chemical industries. We are excited to collaborate with AFSA and its members and work towards driving industry-wide adoption of alternative and animal-free safety assessment methods.
